Kimberly Yen
Pediatric Ophthalmology and Strabismus Specialist Houston, TX
NPI 1487643847 CMS profile 946368
6701 Fannin St, Suite 510.00, Houston, TX 77030
General payments
$0
Research payments
$0
Ownership & investment interest
$0
The CMS Open Payments record contains no reported payments to Kimberly Yen of Houston, TX.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
Other Pediatric Ophthalmology and Strabismus Specialist in Texas
Robert Gross
Pediatric Ophthalmology and Strabismus Specialist · Dallas, TX
Charlotte Akor
Pediatric Ophthalmology and Strabismus Specialist · Corpus Christi, TX
Erica Luse
Pediatric Ophthalmology and Strabismus Specialist · Houston, TX
Adam Cantor
Pediatric Ophthalmology and Strabismus Specialist · Houston, TX
Jessica Thayer
Pediatric Ophthalmology and Strabismus Specialist · Frisco, TX
David Weakley
Pediatric Ophthalmology and Strabismus Specialist · Dallas, TX
Related records
Pediatric Ophthalmology and Strabismus Specialist in Texas
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Ophthalmology and Strabismus Specialist
Everyone recorded under this specialty, nationwide.
Doctors in Texas
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.